F*CK CANCER
8 min readFrom Chapter 2 — Understanding Cancer and Its Diverse Battlegrounds of the book

Cancer Diagnosis Explained: Biopsies, PET Scans & Blood Tests

What a biopsy really tells you, why PET scans hunt sugar, and how liquid biopsies detect cancer in blood. Chapter 2 of F*CK CANCER, explained for patients and families.

cancer diagnosisbiopsyPET scanliquid biopsycancer screening

Nobody fights well what they cannot see. Before the book opens its arsenal of treatments, Chapter 2 does something just as important: it teaches you to read the battlefield — how cancer is found, measured, and tracked, and what each test can and cannot tell you.

What a biopsy actually tells you (and what it doesn't)

A biopsy remains the definitive cancer diagnosis: a small sample of the suspicious tissue, examined by a pathologist. But the report that comes back contains far more than "cancer" or "not cancer," and Chapter 2 walks you through reading it:

  • Grade — how abnormal the cells look, which hints at how fast the tumor may grow
  • Margins — whether surgeons removed the entire tumor or left cells behind
  • Receptors and markers — hormone receptors, HER2, PD-L1 and others that determine which targeted therapies and immunotherapies have a chance of working

The chapter is also honest about limits. A needle samples one spot in a tumor that may contain many different cell populations; the part that kills may not be the part that was sampled. Understanding that limitation is the first step toward the better tools below.

Imaging the battleground

CT scans show structure — where a mass is and how big. MRI shows soft-tissue detail. But the star of the chapter is the PET scan, because it doesn't photograph anatomy at all: it photographs metabolism. A radioactive glucose analog is injected, and the tissues that gorge on sugar light up. Tumors — sugar addicts by nature, as Chapter 1 explains — glow against the background. A PET scan is the Warburg effect turned into a camera.

Blood tests and the liquid biopsy revolution

The most exciting frontier in diagnosis draws blood instead of cutting tissue. Chapter 2 covers two generations of it:

  1. Tumor markers — proteins like PSA, CA-125, and CEA that can signal cancer activity, useful for tracking known disease but too imprecise to diagnose alone
  2. Liquid biopsies — tests that detect fragments of tumor DNA shed into the bloodstream, capable of finding recurrence earlier than imaging and, increasingly, of screening for cancer before symptoms ever appear

A liquid biopsy can capture DNA from every part of a tumor at once — solving the sampling problem that limits needle biopsies — and it can be repeated as often as needed without a single incision. The Cure Finder profiles where the evidence stands for these blood-based approaches.

Why this matters to your fight

Patients who understand their diagnosis negotiate from strength. You can ask whether your tumor was tested for the markers that unlock targeted drugs. You can ask whether a liquid biopsy makes sense for monitoring. You can read your own pathology report instead of waiting for someone to translate it.

That is the point of the book's approach: knowledge first, weapons second. Every test in this chapter is explained in patient language in the book, and the diagnostic entries are free on this site — because the family reading a pathology report at midnight deserves answers that don't wait for an appointment.

Educational content, not medical advice. Decisions about testing and diagnosis belong with your medical team.

Frequently asked questions

What is a liquid biopsy for cancer?

A liquid biopsy is a blood test that detects tumor DNA, circulating tumor cells, or other cancer signals without a surgical sample. It can track treatment response, spot recurrence earlier than imaging, and reveal targetable mutations.

What does a PET scan actually show?

A PET scan highlights cells consuming large amounts of glucose. Because most cancers are sugar-hungry, tumors light up as bright spots, helping doctors stage disease, find spread, and judge whether treatment is working.

Why does cancer staging matter?

Staging describes how far cancer has spread, from stage 1 localized disease to stage 4 metastatic disease. It determines which treatments are realistic, what the goals of therapy are, and which clinical trials a patient qualifies for.